Literature DB >> 16470551

Germline LEMD3 mutations are rare in sporadic patients with isolated melorheostosis.

Jan Hellemans1, Philippe Debeer, Michael Wright, Andreas Janecke, Klaus W Kjaer, Peter C M Verdonk, Ravi Savarirayan, Lina Basel, Celia Moss, Johannes Roth, Albert David, Anne De Paepe, Paul Coucke, Geert R Mortier.   

Abstract

To further explore the allelic heterogeneity within the group of LEMD3-related disorders, we have screened a larger series of patients including 5 probands with osteopoikilosis or Buschke-Ollendorff syndrome (BOS), 2 families with the co-occurrence of melorheostosis and BOS, and 12 unrelated patients with isolated melorheostosis. Seven novel LEMD3 mutations were identified, all predicted to result in loss-of-function of the protein. We confirm that loss-of-function mutations in the LEMD3 gene can result in either osteopoikilosis or BOS. However, LEMD3 germline mutations were only found in two melorheostosis patients belonging to a different BOS family and one sporadic patient with melorheostosis. The additional presence of osteopoikilosis lesions in these patients seemed to distinguish them from the group of sporadic melorheostosis patients where no germline LEMD3 mutation was identified. Somatic mosaicism for a LEMD3 mutation in the latter group was also not observed, and therefore we must conclude that the genetic defect in the majority of sporadic and isolated melorheostosis remains unknown. 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16470551     DOI: 10.1002/humu.9403

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  20 in total

1.  Osteopoikilosis, short stature and mental retardation as key features of a new microdeletion syndrome on 12q14.

Authors:  Björn Menten; Karen Buysse; Farah Zahir; Jan Hellemans; Sara J Hamilton; Teresa Costa; Carrie Fagerstrom; George Anadiotis; Daniel Kingsbury; Barbara C McGillivray; Marco A Marra; Jan M Friedman; Frank Speleman; Geert Mortier
Journal:  J Med Genet       Date:  2007-01-12       Impact factor: 6.318

2.  A novel heterozygous splice-site mutation of LEM domain-containing 3 in a Japanese kindred with Buschke-Ollendorff syndrome.

Authors:  H Kobayashi; M Kasahara; M Hino; S Takahara; K Ikeda; C Son; T Iwakura; N Matsuoka; A Yoshimoto; N Ohgo; R Kasai; T Ishihara; Y Ogawa
Journal:  J Endocrinol Invest       Date:  2007-03       Impact factor: 4.256

3.  Melorheostosis of the sacrum causing acute-onset neurological symptoms.

Authors:  JoongChul Yoon; Laila Al Shafai; Ayoub Nahal; Robert E Turcotte; Marie-Hélène Martin
Journal:  Skeletal Radiol       Date:  2011-06-12       Impact factor: 2.199

4.  Melorheostosis: Exome sequencing of an associated dermatosis implicates postzygotic mosaicism of mutated KRAS.

Authors:  Michael P Whyte; Malachi Griffith; Lee Trani; Steven Mumm; Gary S Gottesman; William H McAlister; Kilannin Krysiak; Robert Lesurf; Zachary L Skidmore; Katie M Campbell; Ilana S Rosman; Susan Bayliss; Vinieth N Bijanki; Angela Nenninger; Brian A Van Tine; Obi L Griffith; Elaine R Mardis
Journal:  Bone       Date:  2017-04-21       Impact factor: 4.398

Review 5.  Human Genetics of Sclerosing Bone Disorders.

Authors:  Raphaël De Ridder; Eveline Boudin; Geert Mortier; Wim Van Hul
Journal:  Curr Osteoporos Rep       Date:  2018-06       Impact factor: 5.096

6.  MAN1 Restricts BMP Signaling During Synaptic Growth in Drosophila.

Authors:  Ulrike Laugks; Marie Hieke; Nicole Wagner
Journal:  Cell Mol Neurobiol       Date:  2016-11-15       Impact factor: 5.046

Review 7.  Identification of a novel LEMD3 Y871X mutation in a three-generation family with osteopoikilosis and review of the literature.

Authors:  Q Zhang; Z H Mo; C S Dong; F Yang; Y H Xie; P Jin
Journal:  J Endocrinol Invest       Date:  2015-12-22       Impact factor: 4.256

Review 8.  Osteopetrosis.

Authors:  Zornitza Stark; Ravi Savarirayan
Journal:  Orphanet J Rare Dis       Date:  2009-02-20       Impact factor: 4.123

9.  Osteopoikilosis and multiple exostoses caused by novel mutations in LEMD3 and EXT1 genes respectively--coincidence within one family.

Authors:  Sevjidmaa Baasanjav; Aleksander Jamsheer; Mateusz Kolanczyk; Denise Horn; Tomasz Latos; Katrin Hoffmann; Anna Latos-Bielenska; Stefan Mundlos
Journal:  BMC Med Genet       Date:  2010-07-09       Impact factor: 2.103

10.  [(Over-)flowing bone: the rare disease of melorheostosis: clinical presentation and therapeutic concepts demonstrated by three cases].

Authors:  E Hesse; J Brand; L Bastian; C Krettek; R Meller
Journal:  Unfallchirurg       Date:  2008-07       Impact factor: 1.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.